Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: A retrospective analysis of phase 2 and phase 3 trials Academic Article uri icon

Overview

MeSH Major

  • Angiogenic Proteins
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Carcinoma, Renal Cell
  • Cytokines
  • Kidney Neoplasms
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Sulfonamides

abstract

  • GlaxoSmithKline.

publication date

  • August 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(12)70241-3

PubMed ID

  • 22759480

Additional Document Info

start page

  • 827

end page

  • 37

volume

  • 13

number

  • 8